Replies to post #259211 on Avid Bioservices Inc (CDMO)

[Carboat]

Yes the mgmt. is an issue and the bod a bigger one, but if bavi worked people would overlook that. The PII results are dismissed at this point. They were questionable for many reasons in the first place (trial size etc.) and now that the PIII failed and pphm has stopped all bavi/chemo it matters not. Now pphm needs a successful trial to have anyone step up with significant cash - oh wait they have no trials. Can you imagine going to Sr. Mgmt and bod and saying "we want to invest/acquire pphm .... yes, the company with the botched PII, failed PIII, weak mgmt. and sleazy penny stock bod" talk about a career ender!

[bfiest]

The primary point is we need to increase our expectations with this team now. There needs to be accountability in this process. They have the entire picture. They need to make the correct strategic moves to ensure they bring the highest value. For all we know Astra Zeneca wanted an exclusive arrangement and was willing to pay for it with more than drug availability. Did they refuse that arrangement? That is a possibility. If the data is not there yet they need to control costs until they get the data they need to ink a deal. They cannot continue down this same path of independence and under-performance. And if they do there needs to be a complete restructuring of this company to meet their responsibilities. We need to hold them to their fiduciary responsibilities. Its our inherent right. I believe they will make the correct moves. Raise expectations. Trust but verify.